IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water, Livestock, Poultry and Dairy (LPD), and Other. The CAG segment provides diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment offers innovative testing solutions for easy, rapid, and accurate detection and quantification of various microbiological parameters in water. The LPD segment develops diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk and food. The Other segment is composed of products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983, and is headquartered in Westbrook, ME.

LifeScan manufactures and markets blood glucose monitoring systems. The company’s product portfolio includes blood glucose meters, test strips, lancing devices, and diabetes management software solutions, hospital meters, data management systems, glucose control solutions, and linearity test kits. Additionally, the company provides pre-installation project management, installation, and post installation support services, including on-site and on-line training programs through authorized distributors such as doctors, pharmacists, and diabetes educators. Lifescan was founded in 1981 and is headquartered in Milpitas, California.  The company currently operates as a subsidiary of Johnson & Johnson and has facilities in Inverness, Scotland; Burnaby, British Columbia, Canada; and Cabo Rojo, Puerto Rico.

Miles Laboratories, Inc., part of Bayer AG, is a company headquartered in Rexdale, ON, Canada, that manufactures pharmaceutical products.

Part of Roche Holding AG, Roche Diabetes Care GmbH is a German company located in Mannheim that develops medicines and medical equipment. It was founded in 2014. Michael Wöhler is currently the CEO of the firm.\nThe company says this about itself: Roche Diabetes Care has been pioneering innovative diabetes technologies and services for more than 40 years. More than 5,500 employees in over 100 markets worldwide work every day to support people with diabetes and those at risk to achieve more time in their target ranges and experience true relief from the daily therapy routines. Being a global leader in integrated Personalised Diabetes Management (iPDM), Roche Diabetes Care collaborates with thought leaders around the globe, including people with diabetes, caregivers, healthcare providers and payers. Roche Diabetes Care aims to transform and advance care provision and foster sustainable care structures. Under the brands RocheDiabetes, Accu-Chek and mySugr, comprising glucose monitoring, insulin delivery systems and digital solutions, Roche Diabetes Care unites with its partners to create patient-centred value. By building and collaborating in an open ecosystem, connecting devices and digital solutions as well as contextualising relevant data points, Roche Diabetes Care enables deeper insights and a better understanding of the disease, leading to personalised and effective therapy adjustments.

Healthy.io is a pioneer in turning the smartphone camera into a clinical grade medical device. Founded in 2013 by founder and CEO, Yonatan Adiri, it took us only three years to reach from idea to global revenues through successful clinical trials. Our first product, Dip.io, is the world’s first clinically approved home urinalysis kit. The product effectively turns the smartphone into a clinical grade urinalysis device, enabling the layperson to conduct clinically required urine testing with a simple smartphone scan. Dip.io was followed by ACR - a second urinalysis test that lets people with diabetes or high blood pressure reliably test themselves at home for kidney disease. The product achieved 99% usability success and is being rolled out for large population screening in Europe, using digital technology to change the dynamics of chronic kidney disease prevention. Our second product family - Chronic wound monitoring - is an assessment tool to analyze chronic wounds over time and facilitate better care coordination.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

MicroDiag Biomedicine focuses on the treatment of cancer, Alzheimer's, acute infectious diseases, and other major diseases. The company was founded in 2008 and is headquartered in Suzhou, Jiangsu, China.

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and MedTech. The Consumer Health segment includes products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The MedTech segment offers products used in the interventional solutions. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Roche Diabetes Care, Inc., a subsidiary of Roche Holding AG, is an American company located in Indianapolis, IN. The firm develops portable medical devices incorporating optical sensors for blood and gas.

HitGen, Inc. engages in the provision deoxyribonucleic acid encoded compound library (DEL) for research and development of seed and lead compounds. It offers DEL screening and library customization, chemical synthesis, and new drug research and development project transfer services. The company was founded by Jin Li on February 22, 2012 and is headquartered in Chengdu, China.

Changshu Changjiang Biotechnology Co., Ltd., established on 2016-03-15, Business scope includes biotechnology promotion and services;Production of medical clinical testing analyzers and in vitro diagnostic reagents;Sales of Medical Devices;Engaged in the import and export of goods and technology,Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) General project:software development;software sales(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Miles is a mobile app that automatically tracks and logs mileage for business purposes. Miles users can now create and export their mileage logs without the need of manual input.

Bioda Biotechnology (Wuhan) Co., Ltd., established on 2011-11-30, The business scope includes the research and development of diagnostic reagents and diagnostic reagent instruments;Research and development of electronic instruments,production and sales,Software development and sales;Class II Medical Devices:6840Production, wholesale and retail of clinical laboratory analysis instruments and in vitro diagnostic reagents;the first sort,Class II,Production, wholesale and retail of Class III medical devices;cosmetic,food,daily necessities,Production of disinfection products,Wholesale and retail;Import and export,Technology Import and Export,Agent import and export(Does not contain goods or technologies that are prohibited or restricted from import and export by the state).(Projects subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Siemens Healthcare Diagnostics, Inc. engages in the vitro diagnostics. It provides healthcare professionals in hospital, reference, and physician office laboratories and point-of-care settings with the vital information required to accurately diagnose, treat, and monitor patients. The company is headquartered in Tarrytown, NY.

DuPont Pharmaceuticals Co. researches and develops pharmaceuticals and imaging products to treat diseases. It focuses on pharmaceuticals to treat unmet medical needs in the fight against HIV, cardiovascular disease, central nervous system disorders, cancer and arthritis-related disorders. The company is located in Wilmington, DE.

Zhejiang Jushi Information Technology Co., Ltd., established on 2019-04-01, Business scope includes information technology,Technology development of electronic products,Technical Services,technical consulting;Various sensors,Automatic measurement and data processing device,Supporting electronic and optoelectronic components and systems,camera,lighting equipment,precision instrument,power supply,Programmable controllers and other power control or distribution devices,Parts for barcode readers and above,appendix,Wholesale of accessory products,processing,commission agent(except auction),Trade information consultation;Various sensors,Programmable Controllers,Outsourced processing of barcode readers;Repair of the above products;computer software design,to develop,Production and Technical Services;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval)(Except those involving the implementation of special access management measures stipulated by the state).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)